Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RFWD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDC5L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929087 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HNRNPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF38A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFCAB14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MANF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PI4KB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL2BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNW1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on